Rosetta Genomics Ltd. (Rosetta) develops, validates, and commercializes a range of diagnostic tests based on microRNAs. ROSG stock price soared 34.46%, or $1.63, to $6.36, leading the top performing stocks today after Aegis initiated coverage with a buy rating and set a $16.00 target price on this stock. Volume exploded from the daily average of 1.02 million shares to 17.65 million shares.
ROSG stock moved up 1.89%, in the after-hours trading.
ROSG stock price has a 52-week range between $1.40 and $26.70. Rosetta Genomics has a market cap of $4.46 million.